Published in Eur J Immunol on March 01, 1981
Specific in vitro antibody response to varicella zoster. Clin Exp Immunol (1981) 1.15
The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes. Immunology (1989) 1.06
Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. J Clin Invest (1983) 0.95
Generation of suppressor cells in the autologous mixed lymphocyte reaction. Clin Exp Immunol (1981) 0.94
Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms. Immunology (1991) 0.92
Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals. Immunology (1988) 0.88
In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann Rheum Dis (1988) 0.88
Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 0.87
Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia. J Clin Invest (1983) 0.85
Accessory cell and HLA compatibility requirements for the generation of specific in-vitro antibody responses to influenza virus by human blood lymphocytes. Immunology (1983) 0.85
Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene. J Exp Med (1982) 0.82
Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes. J Clin Invest (1983) 0.82
Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro. Immunology (1986) 0.81
Induction of a T-cell mediated suppressor activity by soluble products from antigen-specific helper/inducer human T-cell lines. Immunology (1983) 0.81
Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens. Immunology (1987) 0.79
Specific antibody responses by high- and low-density human peripheral blood B cells: T-helper cells and T-cell replacing factor (TRF) act on different B-cell subpopulations. Immunology (1987) 0.75
Relative sensitivity of human T cell subsets to deoxyadenosine toxicity. Clin Exp Immunol (1984) 0.75
Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol (1981) 5.32
Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology (1986) 4.00
Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood (1996) 2.21
A small nucleolar RNA requirement for site-specific ribose methylation of rRNA in Xenopus. Proc Natl Acad Sci U S A (1996) 2.18
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Specific in vitro antibody response to influenza virus by human blood lymphocytes. Nature (1979) 2.08
The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol (2005) 2.01
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet (1998) 1.83
Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol (2001) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Neurological complications of celiac disease: a rare but continuing problem. Am J Gastroenterol (1996) 1.68
Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol (1987) 1.62
Childhood empyema. Thorax (1999) 1.55
The division of neuronal progenitor cells during migration in the neonatal mammalian forebrain. Mol Cell Neurosci (1995) 1.53
Haemorrheological alterations associated with competitive racing activity in horses: implications for exercise-induced pulmonary haemorrhage (EIPH) Equine Vet J (1998) 1.46
Survival and settlement success of coral planulae: independent and synergistic effects of macroalgae and microbes. Oecologia (2008) 1.46
Chemically defined medium for oral microorganisms. J Clin Microbiol (1985) 1.43
Effects of Salinity on Primary Processes of Photosynthesis in the Red Alga Porphyra perforata. Plant Physiol (1983) 1.41
Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders. Clin Exp Immunol (1981) 1.35
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg (2010) 1.34
Regulation of mitochondrial alpha-ketoglutarate metabolism by product inhibition at alpha-ketoglutarate dehydrogenase. J Biol Chem (1974) 1.33
The effect of transfer to a warm environment (30 degree C.) on the metabolic response to injury. Br J Surg (1968) 1.31
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. JAMA (1998) 1.27
Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr (1982) 1.26
Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology (2001) 1.26
Clinical and microbiological features of refractory periodontitis subjects. J Clin Periodontol (1998) 1.25
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis (2007) 1.23
Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J Infect Dis (1987) 1.23
The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis (1991) 1.22
New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. J Med Chem (1998) 1.21
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol (1994) 1.20
Rapid method for the purification of DNA from subgingival microorganisms. Oral Microbiol Immunol (1989) 1.19
Close linkage of random DNA fragments from Xq 21.3-22 to X-linked agammaglobulinaemia (XLA). Hum Genet (1987) 1.16
Treatment of haemangioendotheliomas with alpha interferon. Lancet (1989) 1.15
Specific in vitro antibody response to varicella zoster. Clin Exp Immunol (1981) 1.15
Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits. Anesth Analg (1985) 1.13
Activities of NAD-specific and NADP-specific isocitrate dehydrogenases in rat-liver mitochondria. Studies with D-threo-alpha-methylisocitrate. Eur J Biochem (1979) 1.12
Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. Health Technol Assess (2004) 1.11
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol (1999) 1.09
Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Symp Soc Exp Biol (1973) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Failure of exogenous gonadotrophin controlled ovulation to cause digit abnormalities in mice. Nature (1975) 1.08
Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS). Clin Exp Immunol (2000) 1.07
Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect Immun (2001) 1.07
Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J Clin Microbiol (1991) 1.06
Biosynthesis of water-soluble vitamins. Annu Rev Biochem (1974) 1.06
The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury (2008) 1.06
Chin morphology and sexual dimorphism in the fossil hominid mandible sample from Klasies River Mouth. Am J Phys Anthropol (1996) 1.04
Characterization of the major DNA repair methyltransferase activity in unadapted Escherichia coli and identification of a similar activity in Salmonella typhimurium. J Bacteriol (1989) 1.04
A micromethod for the induction and assay of specific in vitro antibody responses by human lymphocytes. J Immunol Methods (1981) 1.04
Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int Immunol (1996) 1.04
B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Eur J Immunol (1986) 1.03
Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03
Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart. J Mol Cell Cardiol (1971) 1.03
Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc (1989) 1.02
Abnormal oesophageal motility in patients with chronic cough. Thorax (2003) 1.02
A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection. FEBS Lett (2001) 1.02
Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J Virol (1996) 1.01
Medication compliance and substance abuse among schizophrenic patients. Hosp Community Psychiatry (1990) 1.01
Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors. Int Immunol (1991) 1.00
Phenotype of human T helper and suppressor cells in an in vitro specific antibody response. Eur J Immunol (1982) 0.99
Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4. Eur J Immunol (1991) 0.97
Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur J Immunol (1990) 0.97
Metabolism after injury. I. Effects of severity, nutrition, and environmental temperatue on protein potassium, zinc, and creatine. Br J Surg (1972) 0.97
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses (1997) 0.96
Hyperosmolarity as the stimulus to asthma induced by hyperventilation? J Allergy Clin Immunol (1986) 0.95
Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1996) 0.94
The relationship between metabolic state and total CoA content of rat liver and heart. J Nutr (1978) 0.94
Signs and symptoms of hangover: prevalence and relationship to alcohol use in a general adult population. Drug Alcohol Depend (1983) 0.94
Enumeration of subgingival species on primary isolation plates using colony lifts. Oral Microbiol Immunol (1992) 0.94
Sclerodermatous graft-versus-host disease limited to an area of measles exanthem. Lancet (1978) 0.94
The peptide hormone pQDLDHVFLRFamide (crustacean myosuppressin) modulates the Homarus americanus cardiac neuromuscular system at multiple sites. J Exp Biol (2009) 0.94
Expert variability provides perspective on the strengths and weaknesses of citizen-driven intertidal monitoring program. Ecol Appl (2012) 0.93
The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure. Biochemistry (1976) 0.93
Choline therapy in Alzheimer's disease. Lancet (1978) 0.93
Use of a safety climate questionnaire in UK health care: factor structure, reliability and usability. Qual Saf Health Care (2006) 0.93
Late-form hemorrhagic disease of the newborn: a fatal case report with illustration of investigations that may assist in avoiding the mistaken diagnosis of child abuse. Am J Forensic Med Pathol (1999) 0.93
Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunology (1989) 0.93
Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms. Immunology (1991) 0.92
Development of a broth medium for Bacteroides forsythus. J Clin Microbiol (1987) 0.92
Inhibitors of inosinate dehydrogenase activity in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol (1974) 0.92
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain (1999) 0.92
Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells. J Immunol (1982) 0.92
Abnormalities of T-cell subsets in patients with neutropenia and an excess of lymphocytes in the bone marrow. Br J Haematol (1981) 0.92
Gliomatosis cerebri: a clinical, radiological and pathological report of four cases. Br J Neurosurg (1991) 0.91
Treatment of acute cold agglutinin hemolytic anemia with transfusion of adult i RBCs. JAMA (1974) 0.91
Possible biochemical basis of memory disorder in Alzheimer disease. Ann Neurol (1978) 0.91
The glyceraldehyde 3-phosphate dehydrogenases of liver and muscle. Cooperative interactions and conditions for functional reversibility. J Biol Chem (1972) 0.91
Quality of well-being predicts survival in lung transplantation candidates. Am J Respir Crit Care Med (1995) 0.91
Cerebellar and labyrinthine influences on single vestibular neurons identified by natural stimuli. J Neurophysiol (1971) 0.91
Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology (1983) 0.91
Antigen specificity and frequency of autologous and allogeneic helper T cells in the in vitro production of antibody against influenza virus by human blood lymphocytes. Eur J Immunol (1982) 0.90
Regulation of coenzyme A biosynthesis by glucagon and glucocorticoid in adult rat liver parenchymal cells. Biochem J (1980) 0.90
Immune function in aged mice. V. Role of suppressor cells. J Immunol (1980) 0.90